Stockwinners Market Radar for November 13, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:17 EDT MyoKardia: Machine learning algorithm results lend themselves to further testing - MyoKardia presented results from testing a novel machine learning algorithm intended to identify patients with obstructive hypertrophic cardiomyopathy during a late-breaker session at the American Heart Association Scientific Sessions. MyoKardia designed an exploratory digital health substudy as part of the Phase 2 PIONEER-HCM trial of mavacamten to determine if an optical biosensor, similar to those that monitor heart rate on commercially available fitness trackers, could identify patients with oHCM. Using an investigational wrist-worn photoplethysmography digital health device, arterial pulse wave patterns of oHCM patients were shown to be distinct from those of individuals without oHCM. After training and cross-validation, MyoKardia's proprietary machine learning algorithm identified individuals with oHCM with 95 percent accuracy, with a sensitivity of 0.95 and a specificity of 0.95. "We believe the data obtained in this study provide proof-of-principle for the possible use of wearable PPG technology to screen for obstructive hypertrophic cardiomyopathy," said Charles Wolfus, Executive Director, Digital Health, Technology and Business Operations at MyoKardia. "These results lend themselves to further testing of our machine learning algorithms, with the potential to expand its application to different wrist-worn wearable platforms, to monitor for treatment effects in oHCM patients, and to screen for other types of cardiomyopathy."

18:39 EDT Electronics for Imaging to delay filing quarterly report on Form 10-Q - Electronics For Imaging announced that the company filed a Form 12b-25 regarding its Form 10-Q for the period ended September 30, 2017. In the filing, the company stated that the preliminary earnings announcement for the quarter ended September 30, 2017 included an expense related to a write-off during the quarter of certain inventory, a majority of which the Company acquired as part of its July 2015 acquisition of Reggiani Macchine S.P.A. EFI has just concluded negotiations with the prior owners to recover part of this expense, and, as a result, the expense has been reduced. The company is evaluating the accounting impacts of the write-off and reduction of the inventory expense and related settlement, and whether this affects management's assessment of the effectiveness of its current and historical disclosure controls and internal control over financial reporting. The company does not expect any negative impact to any previously reported financial results. Accordingly, EFI was not able to complete the preparation, review and filing of its Form 10-Q for the quarter ended September 30, 2017 within the prescribed time period without unreasonable effort or expense, and expects to file its Form 10-Q as soon as practicable.

18:02 EDT Heartland Financial to acquire Signature Bancshares for $53.4M - Heartland Financial USA and Minnetonka, MN-based Signature Bancshares, Inc are pleased to announce they have entered into a definitive merger agreement pursuant to which Signature will be acquired by Heartland. The acquisition marks Heartland's 20th acquisition since 1994, and its 13th transaction in the past six years. Based on Heartland's closing common stock price of $47.30 per share on November 10, 2017, the stock and cash transaction is valued at approximately $53.4 million. The actual transaction value will change due to fluctuations in the price of Heartland common stock. Signature Bank is a commercial and private bank, headquartered in Minnetonka, MN, with approximately $390 million in total assets, $326 million in net loans outstanding and $339 million in deposits as of September 30, 2017. Simultaneously with the merger of Signature with and into Heartland, Signature Bank will merge with and into Heartland's Minnesota-based subsidiary, Minnesota Bank & Trust. Together Signature Bank and Minnesota Bank & Trust will have over $600 million in combined assets and operate as one of Heartland's locally managed subsidiary banks.

18:01 EDT Celanese obtains preliminary injunction against Falken Trade Polska - Celanese announced that it has successfully obtained a preliminary injunction against Falken Trade Polska sp. z o.o. sp.k., a European distributor of Acesulfame Potassium, a high-potency sweetener subject to recently granted European Patent No. 2 861 569. The injunction prevents the Distributor from continuing to sell infringing Ace-K sweetener. Violation of the preliminary injunction could result in fines, penalties and imprisonment. Celanese continues to invest in manufacturing and quality improvements and is dedicated to robust research, development and customer support for the Sunett sweetener products manufactured by its patented processes. The company will protect these investments to supply customers with quality engineered products, and will vigorously defend against unlawful manufacturing, importing, purchasing, selling and using of its patented technology in the United States, Europe, China and globally.

17:47 EDT Source Capital declares special distribution of 44c per share - The record date is November 24, with pay date of December 15. The ex date is November 21.

17:24 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Remark Holdings (MARK), up 11.1%... DHT Holdings (DHT), up 4.9%. ALSO HIGHER: Buffalo Wild Wings (BWLD), up 27.9% after the Wall Street Journal reported that Roark Capital offered over $150 per share to acquire the company... TRACON Pharmaceuticals (TCON), up 19.6% after the company reported "positive" results from its Phase 1 Trial of TRC102 and Fludara. DOWN AFTER EARNINGS: Everspin Technologies (MRAM), down 11.1%... Switch (SWCH), down 3.8%. ALSO LOWER: Myomo (MYO), down 15.7% after it filed to sell common stock and warrants... ProQR Therapeutics (PRQR), down 9.4% after it filed to sell common stock... Third Point Reinsurance (TPRE), down 3.9% after it filed to sell 15M shares of common stock for holders... Appian (APPN), down 3.7% after it filed to sell 3.8M shares of Class A common stock for holders.

17:18 EDT Celsion files for the evaluation of GEN-1 to treat ovarian cancer - Celsion Corporation announced the submission of its Phase I/II clinical trial protocol to the U.S. Food and Drug Administration for GEN-1, the company's DNA-based immunotherapy for the localized treatment of ovarian cancer. The protocol, developed in conjunction with guidance from the company's Medical Advisory board, is designed with a single dose escalation to evaluate the safety and biological activity of GEN-1 at 100mg/m in newly diagnosed Stage III/IV ovarian cancer patients, followed by a continuation at the selected dose in Phase II in a 90 patient 1 to 1 randomized study. GEN-1 has demonstrated encouraging safety and efficacy data in a recently completed dose escalating Phase IB trial in combination with neoadjuvant chemotherapy, the standard of care for patients newly diagnosed with ovarian cancer. Concurrently with neoadjuvant chemotherapy, enrolled patients received escalating weekly doses of GEN-1, from levels beginning at 36mg/m, to 47mg/m, 61mg/m and 79mg/m weekly for 8 treatments in total, followed by interval debulking surgery.

17:16 EDT Leon Cooperman reports 5.84% passive stake in AMC Networks

17:09 EDT Francesca's names Ivy Spargo CMO - Francesca's (FRAN) announced the appointment of Ivy Spargo as senior VP and CMO. Spargo will assume her role leading the company's merchandising team on November 27. Spargo was most recently senior VP, general merchandise manager of Sephora inside JCPenney (JCP) and women's specialty apparel for JCPenney.

17:05 EDT Live Nation CEO sells 210,000 common shares - In a regulatory filing, Live Nation president and CEO Michael Rapino disclosed the sale of 210,000 common shares in three tranches priced in the range of $44.68-$45.46 per share.

17:03 EDT United Continental recommends that shareholders reject mini-tender by TRC - United Continental Holdings announced that it received notice of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 2,000,000 shares of UAL's common stock at a price of $57.00 per share in cash. The offering price is 4.44% below the closing price per share of UAL's common stock on November 3, 2017, the last trading day prior to the date of the offer. The offer is for approximately 0.68 percent of the outstanding shares of UAL common stock.

17:00 EDT BNY Mellon announces organizational changes - The Bank of New York Mellon announced a new organizational and leadership structure, effective January 1, 2018. The new organizational structure creates three new business units under the Investment Services segment: 1) Clearing, Markets and Client Management, 2) Asset Servicing, and 3) Issuer Services. The new units will combine businesses under common leadership that have natural connections and intersections with clients and will work closely together in developing comprehensive solutions. The new structure also allows for more client and business representation on the Executive Committee, the company's most senior management group. Thomas Gibbons has been appointed CEO of Clearing, Markets and Client Management which will include Pershing, Markets, Government Securities Services Corp., Treasury Services and Commercial Payments, Credit Services and Regional Management. This new group brings together all market and credit risk activities where we continue to have multiple opportunities to build more integrated solutions for our clients. Gibbons will remain on the Executive Committee. Reporting to Mr. Gibbons will be Lisa Dolly who will continue to lead Pershing, Michelle Neal who will continue to lead Markets, and Brian Ruane who will continue to lead Government Securities Services Corp. - all will be members of the Executive Committee. Ian Stewart will continue to lead Treasury Services and Commercial Payments, Jeff Landau will continue to lead Credit Services, Adriano Koelle will remain Chairman of Latin America, and David Cruikshank will remain Chairman of APAC and a member of the Executive Committee. Michael Santomassimo has been appointed Chief Financial Officer, succeeding Mr. Gibbons. Santomassimo has been CFO of Investment Services since July 2016. Prior to joining BNY Mellon, Santomassimo spent 11 years at JPMorgan Chase & Co. in a number of key finance leadership roles including as Chief Financial Officer, Banking, which included Investment Banking (Advisory and Equity & Debt Capital Markets), as well as Treasury Services. He also served as Chief Financial Officer, Technology & Operations, for the same division at JPMorgan Chase & Co., Chief Financial Officer of Worldwide Securities Services and CFO of the US Private Bank. Hani Kablawi, currently Head of Investment Services, EMEA, will become CEO of Global Asset Servicing and Chairman of EMEA, and will join the Executive Committee. Francis La Salla, currently CEO, Corporate Trust, will become CEO of Issuer Services (to include Corporate Trust and Depositary Receipts) and will join the Executive Committee. Doug Shulman will continue to lead Operations, reporting to Scharf, and will remain on the Executive Committee. The Executive Committee will also include a new Head of Digital, reporting to Scharf. As is the case with most businesses, technology provides BNY Mellon with more ways than ever to provide advanced services to its clients and drive dramatically improved quality and efficiency. While there are many efforts across the company, BNY Mellon has an opportunity to be bolder in its approach and more consistent in its work in an aggressive pursuit of better solutions for its clients. The company, and ultimately its clients, will benefit from expert leadership with deep knowledge of the business application of data management and analytics, artificial intelligence and machine learning. This function will work with business leaders to understand how to best serve its clients in becoming a digitally focused organization. As a consequence of the flatter organizational structure and business unit re-alignment, Brian Shea, CEO of Investment Services, will be leaving the company, effective December 31, 2017.

16:51 EDT Scopia Capital reports 14.1% passive stake in Entercom

16:49 EDT BNY Mellon names Michael Santomassimo as CFO, succeeding Thomas Gibbons - Santomassimo has been CFO of Investment Services since July 2016. Prior to joining BNY Mellon (BK), Santomassimo spent 11 years at JPMorgan Chase & Co. (JPM) in a number of key finance leadership roles including as Chief Financial Officer, Banking, which included Investment Banking, as well as Treasury Services. Thomas Gibbons has been appointed CEO of Clearing, Markets and Client Management which will include Pershing, Markets, Government Securities Services Corp., Treasury Services and Commercial Payments, Credit Services and Regional Management. This new group brings together all market and credit risk activities where we continue to have multiple opportunities to build more integrated solutions for our clients. Gibbons will remain on the Executive Committee.

16:45 EDT Buffalo Wild Wings up 27% after DJ reports Roark Capital offers to buy company - In after-hours trading, shares are up over 26% to $148.00 per share.

16:37 EDT Amarin says Vascepa showed reductions in atherogenic lipid, inflammatory markers - Amarin Corporation announced an oral presentation titled, "Icosapent Ethyl Reduces Potentially Atherogenic Lipid and Inflammatory Markers in High-Risk Statin-Treated Patients With Stage 3 Chronic Kidney Disease and Persistent High Triglycerides." This oral presentation was held at the American Heart Association 2017 Scientific Sessions in Anaheim, California. Patients with stage 3 chronic kidney disease, or CKD, and persistent high triglycerides, or TG, despite statin therapy have a high risk of cardiovascular disease, or CVD. The presentation of additional data from the phase 3 ANCHOR study of Vascepa showed, in a post hoc analysis, that consistent with overall study results, Vascepa 4 g/day reduced potentially atherogenic lipid and inflammatory markers without raising LDL-C, and with a safety profile similar to placebo in patients with CKD. These hypothesis-generating data warrant further prospective study to determine the clinical benefit of Vascepa, if any, as an adjunct to statin therapy in patients with CKD. The ongoing CVD outcomes trial with prescription, high-dose of icosapent ethyl in addition to statin therapy, REDUCE-IT, while not designed specifically to evaluate CVD outcomes in CKD patients, is expected to include some patients with CKD.

16:34 EDT Summit Hotel Properties CFO Gregory Dowell to retire, Stanner to succeed - Summit Hotel Properties announced that Gregory Dowell, its EVP and CFO, plans to retire from the Company on March 31, 2018. Dowell has been with Summit for over three years and has led the Company's finance and accounting functions through periods of substantial growth and improvement. He has played a key role in the long-term succession planning for the Company and will continue to work closely with his successor during the upcoming transition period. Jonathan Stanner, EVP and Chief Investment Officer, will succeed Dowell as EVP and CFO effective March 31, 2018. Stanner joined the Company in April 2017 and has become an integral member of the management team. Prior to joining Summit, he held various positions at Strategic Hotels and Resorts, including the role of CFO. Stanner will continue to oversee the Company's investment activities following the transition.

16:27 EDT Vereit to sell Cole Capital to affiliate of CIM Group - VEREIT and CIM Group announced the signing of a purchase agreement for the sale of Cole Capital, VEREIT's investment management business, to an affiliate of CIM Group. Currently, Cole has more than $7.6B in assets under management and manages five public non-listed real estate investment trusts: Cole Credit Property Trust IV, Inc., Cole Credit Property Trust V, Inc., Cole Real Estate Income Strategy, Cole Office & Industrial REIT, and Cole Office & Industrial REIT. In connection with the transaction, VEREIT may receive up to $200M, comprised of $120M cash paid at closing under the purchase agreement and up to $80M in fees to be paid under a six-year services agreement based on Cole's future revenues. The services agreement will, among other things, require VEREIT to provide operational real estate support to Cole for approximately one year. Subject to regulatory approvals and customary closing conditions, the transaction is expected to close at the end of the fourth quarter of 2017 or during the first quarter of 2018.

16:23 EDT WesBanco announces merger agreement with First Sentry Bancshares - WesBanco and First Sentry Bancshares jointly announced today that they have executed a definitive Agreement and Plan of Merger providing for the merger of First Sentry with and into WesBanco. James C. Gardill, Chairman of the Board, and Todd F. Clossin, President and CEO, of WesBanco and Robert H. Beymer, Chairman of the Board, and Geoffrey S. Sheils, President and CEO, of First Sentry, made the joint announcement. Under the terms of the Agreement and Plan of Merger, which has been approved by the board of directors of both companies, WesBanco will exchange shares of its common stock for First Sentry common stock, in an all-stock transaction. First Sentry shareholders will be entitled to receive 1.5869 shares of WesBanco common stock for each share of First Sentry common stock for a total value of approximately $64.00 per share or $101.4M (including options) based on the 15-day average closing price of WesBanco common stock ending on November 9, 2017 of $40.33. The merger is expected to qualify as a tax-free reorganization. Excluding certain one-time merger charges, the transaction should be approximately 2.2% accretive to 2018 earnings and 3.3% accretive to 2019 earnings. Estimated tangible book value dilution at closing of approximately 1.2% is expected to be earned back in approximately 2.5 years using the "cross-over" method, including estimated merger-related expenses of approximately $9.9M. The acquisition is subject to the approvals of the appropriate banking regulatory authorities and the approval of the shareholders of First Sentry. The transaction is anticipated to be completed during the first or second quarter of 2018.

16:22 EDT WesBanco announces merger agreement with First Sentry Bancshares -

16:20 EDT Mirati Therapeutics says reprioritizing development programs - Mirati Therapeutics announced that it is reprioritizing its development programs to capitalize on encouraging data and development opportunities in its sitravatinib and KRAS programs. In addition, the Company announced that it has selected a clinical lead and backup compounds in its KRAS program that potently target KRAS G12C mutations. An Investigational New Drug Application submission is expected by the fourth quarter of 2018. The Company also announced it will deprioritize further investment in glesatinib and will pursue opportunities to partner the program. The reallocation of resources will support the acceleration and expansion of the sitravatinib and KRAS programs and is expected to provide funding for operations into late 2019.

16:20 EDT Marathon Petroleum and MPLX LP announce agreement - Marathon Petroleum (MPC) and MPLX LP (MPLX) announced an agreement for the dropdown of refining logistics assets and fuels distribution services to MPLX for total consideration of approximately $8.1 billion. The transaction is expected to close on Feb. 1, 2018, and be immediately accretive to MPLX's distributable cash flow per unit. These assets and services are projected to generate annual earnings before interest, taxes, depreciation and amortization of $1 billion. MPC is contributing these assets and services in exchange for $4.1 billion in cash and MPLX equity valued at approximately $4 billion. The equity to be issued will consist of 111.6 million MPLX common (LP) units and 2.3 million general partner (GP) units to maintain MPC's 2% GP interest in MPLX. Today, MPC also offered to the MPLX board an exchange of its GP economic interests in MPLX, which include incentive distribution rights (IDRs), for newly issued MPLX common units. This transaction is expected to provide a clear valuation for MPC's GP interests in MPLX, and reduce MPLX's cost of capital to support the sustainable long-term growth of the partnership. MPC will continue to own the non-economic general partner interest in MPLX. This transaction is now under review by the conflicts committee of the MPLX board of directors.

16:19 EDT Partner Fund Management reports 5.1% passive stake in Cutera

16:15 EDT Knoll Capital reports 9.9% passive stake in Soligenix

16:14 EDT Lonestar Resources sees 2018 production 10,000-10,700 Boe/d - CEO Bracken commented, "On an annualized basis, our Adjusted EBITDAX increased sequentially from $50.8 million in 2Q17 to $81.2 million in 3Q17, driven by significant growth in production, most particularly oil production while keeping our cash expenses in check. The growth in our third quarter results will serve as a platform for continued in 2018. We forecast that 2018 production will range between 10,000 to 10,700 Boe/d and we currently anticipate that Adjusted EBITDAX will total between $100 and $110 million. Importantly, we expect to achieve this significant growth in production and EBITDAX while also significantly enhancing our credit metrics. We currently anticipate that Debt / EBITDAX will improve to between 2.7x and 2.9x by year-end 2018."

16:12 EDT Myovant Sciences secures flexible financing commitments of up to $140M - "We made significant clinical and corporate progress this quarter as we continue to build Myovant into a leading women's health company. The positive results from Takeda's two Phase 3 studies evaluating the efficacy and safety of relugolix for the treatment of uterine fibroids provide strong support for Myovant's ongoing Phase 3 studies of relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids," stated Lynn Seely, M.D., President and CEO of Myovant Sciences. "In addition, we secured flexible financing commitments of up to $140 million, which puts us in a strong financial position to support the Phase 3 development of relugolix in uterine fibroids, endometriosis and advanced prostate cancer."

16:07 EDT Flagstar Bank to acquire Desert Community Bank branches from East West Bank - Flagstar Bancorp announced that Flagstar Bank, FSB has signed a definitive agreement to acquire eight Desert Community Bank branches in San Bernardino County, Calif., with approximately $600M in deposits and $70M in loans, from East West Bank along with certain related assets. Terms of the transaction were not disclosed. The transaction is subject to regulatory approval and customary closing conditions, and is expected to close in the first half of 2018.

16:05 EDT East West Bancorp to sell Desert Community Bank branches to Flagstar Bancorp - East West Bancorp (EWBC) announced that East West Bank has entered into a purchase and assumption agreement to sell its Desert Community Bank branches and related assets and liabilities to Flagstar Bank, a subsidiary bank of Flagstar Bancorp (FBC). Desert Community Bank consists of eight branches located in the High Desert area of California, and has been operating as a separate division of East West Bank for ten years. The purchase and assumption agreement includes all eight branches, approximately $70M in loans and $600M in deposits. Following the sale, DCB will retain its name and continue to operate as Desert Community Bank, a division of Flagstar Bank. The transaction is subject to regulatory approval and satisfaction of customary closing conditions, and is expected to be completed in the first half of 2018.

16:02 EDT Amgen: New analyses from Repatha study show reduced cardiovascular events - Amgen announced five new subgroup analyses from the Repatha cardiovascular outcomes study that showed the addition of Repatha to statin therapy improved clinical outcomes with significant reduction of cardiovascular events, such as heart attack, also called myocardial infarction or MI, and stroke, in high-risk patients with peripheral artery disease, and in patients with a history of heart attack. The analyses, including two accepted for late-breaker scientific sessions, were presented at the American Heart Association Scientific Sessions 2017. These results highlight Repatha's ability to reduce the residual risk for CV events particularly in high-risk patients with limited treatment options. One analysis showed the addition of Repatha to statin therapy improved clinical outcomes with significant reduction of CV events in patients with a history of PAD. Because of their greater baseline risk of CV events, there was a numerically greater absolute risk reduction (ARR) at 2.5 years in patients with PAD (ARR 4.1 percent, 95 percent CI 2.5-6.7) relative to those without PAD (ARR 1.5 percent, 95 percent CI 0.7-2.2). A separate analysis investigated the efficacy of Repatha in high-risk patients who have experienced a prior heart attack. In that analysis, the ARR was greater (~3 percent ARR over three years) in patients with a history of heart attack within two years compared to those whose heart attack was more than two years past (ARR 1 percent). Additionally, no new safety concerns were identified in these analyses.

15:33 EDT NY DFS fines Credit Suisse $135M for foreign exchange practices - New York Financial Services Superintendent Maria Vullo announced that Credit Suisse agreed to pay a $135M fine as part of a consent order with the New York State Department of Financial Services for violations of New York banking law, including improper efforts with other global banks, front-running client orders, and additional unlawful conduct that disadvantaged customers. The violations announced today stem from an investigation by DFS determining that from at least 2008 to 2015, Credit Suisse consistently engaged in unlawful, unsafe and unsound conduct by failing to implement effective controls over its foreign exchange business. As part of the consent order, Credit Suisse will also engage a consultant, subject to approval by DFS in its sole discretion, to review and report to the Department about the bank's remedial efforts with regards to its FX business.

14:58 EDT People's Utah Bancorp announces completion of merger of Town & Country Bank - People's Utah Bancorp, a bank holding company and parent of People's Intermountain Bank, announced that it completed the merger of Town & Country Bank into PIB. Under the terms of the merger, each outstanding T&C common share converted into the right to receive 0.2917 PUB common shares and $4.23 in cash, including $2M of cash held in escrow that is subject to future indemnification claims. The value of the total deal consideration was approximately $26.8M, including cash of $8.2M and $2M of cash held in escrow.

14:43 EDT T. Rowe Price reports 13.6% passive stake in ANGI Homeservices

14:41 EDT GE Aviation announces Intelligent Network agreement with flydubai - GE Aviation and flydubai announced that they have reached an agreement for GE to provide Intelligent Network software for efficient recovery of disruptions across the airline's fleet of Boeing 737 aircraft. "We require a tool to provide improved Customer Service and operational visibility during interruptions to flight operations. Understanding the total impact to our passengers and our operation is of supreme importance. Intelligent Network provides a clear snapshot of the changes in our daily operations when it comes to any possible disruptions," said Ken Gile, Chief Operating Officer of flydubai.

14:11 EDT Credit Suisse to pay $135M to settle NYDFS probe into foreign exchange practices

13:38 EDT Madison Square Garden President and CEO David O'Connor steps down - The Madison Square Garden Company announced that David O'Connor has stepped down as President and CEO, effective immediately. James Dolan, Executive Chairman, has assumed the additional role of interim CEO.

13:15 EDT Modine to close Gailtal, Austria facility impacting 142 workers - Modine Manufacturing Company announced its intention to close its manufacturing facility in Gailtal, Austria. The closure is expected to impact approximately 142 employees. This action reflects Modine's proactive focus on consistently strengthening its business by reducing excess capacity and by operating scale production facilities across the globe. The Gailtal, Austria plant historically made coils for a variety of end markets and had annual sales of approximately EUR$20M. Modine will provide the affected employees severance benefits and work closely with the local government and works councils to meet all local regulations and to find the best solution for affected employees. "Making the decision to close a facility is never easy," said Dennis Appel, VP, commercial and industrial solutions. "However, our Strengthen, Diversify and Grow strategy remains a core foundational element of our business, and as a result, we continue to look for opportunities to reduce excess capacity. We have therefore made the difficult decision to consolidate our European operations by closing our manufacturing facility in Gailtal, Austria. Further, we are committed to making the transition as seamless as possible for our customers and to assisting our affected employees during the transition."

13:06 EDT Mackenzie Financial reports 10.02% passive stake in Shaw Communications

12:29 EDT Cincinnati selects Constellation as natural gas supplier for second term - For the second consecutive term, the City of Cincinnati has selected Constellation, a subsidiary of Exelon Corporation and a longtime competitive energy supplier in Ohio, to provide monthly variable-rate natural gas supply to more than 40,000 Cincinnati residents and small businesses. According to city officials, the program saved participants a total of $2.1M in 2016, as compared to the Standard Service Offer from the utility during that period of time. In addition, the City of Cincinnati will be able to provide customers with a new enhancement to the program that allows them to reduce their carbon footprint. Through this voluntary program, Constellation will purchase carbon offsets generated from renewable natural gas sources such as landfills or farms to offset CO2 emissions associated with each customer's natural gas use. Under the terms of the new agreement, scheduled to begin with October meter reads and continue through September 2020, the program's monthly variable rate is based on the New York Mercantile Exchange price for natural gas plus a fixed charge of 12.17c per one hundred cubic feet. At points during the 36-month agreement, if the city determines market conditions are favorable, the program rate may be converted to a fixed rate.

11:59 EDT KBR slips after Ultra Electronics signals warning on U.K. market - Weakness in shares of KBR (KBR) has been attributed by traders to the warning issued by Ultra Electronics Holdings of the U.K., according to Bloomberg. On November 10, the international defense, security, transport and energy group issued a trading statement that included the following warning about its current outlook: "The majority of the Group's markets have been satisfactory, however the UK market has been difficult and has become increasingly so in the second half. There are mounting pressures in the funding of UK defence programmes and this has resulted in the UK MoD pausing, cancelling or delaying numerous programmes. Within the last few weeks a number of our UK orders budgeted for 2017 have been affected. Consequently, the Group now expects full year total revenue to be around GBP 770m and organic revenue to show a decline of about 4%." In midday trading, KBR shares are down 10% to $18.76. Meanwhile, shares of BAE Systems (BAESY) are down 4% and Kratos Defense (KTOS) is down nearly 6%.

11:37 EDT WisdomTree slides as ETF Securities deal seen lowering takeover odds - Shares of WisdomTree (WETF) are sliding after it announced that it is acquiring certain assets of ETF Securities and is adjusting its quarterly dividend to 3c per share. Commenting on the deal, Goldman Sachs analyst Alexander Blostein argued that it reduces the probability of WisdomTree being acquired in the near-term. ACQUISITION OF ASSETS: WisdomTree Investments announced that it has entered into a definitive agreement to acquire ETF Securities' European exchange-traded commodity, currency and short-and-leveraged business, which includes $17.6B of assets under management as of November 9, 2017. With the addition of the acquired business, WisdomTree's assets under management would total approximately $66B globally on a pro-forma basis, as of November 9. Under the terms of the agreement, WisdomTree will exchange $253M of cash and stock consideration of 30M WisdomTree shares for the acquired business. Based on Friday's market close price, the total consideration is valued at $611M. Excluding one-time transaction and integration costs, WisdomTree expects that the acquisition will be immediately accretive to its earnings per share. Subject to regulatory approval and other customary closing conditions, the transaction is expected to close in late Q1 of 2018. LOWER DIVIDEND: Meanwhile, as part of the acquisition deal announcement, WisdomTree said it will adjust its quarterly dividend to 3c per share, starting with the dividend scheduled for payment in the first quarter of 2018. "This dividend level appropriately balances our new capital structure and allows for the pursuit of future growth opportunities while continuing to return capital to shareholders," the company stated. REDUCED ACQUISITION PROBABILITY: Commenting on the news, Goldman Sachs' Blostein told investors that as part of the proposed deal, WisdomTree will assume $200M of debt, which management stated will be a permanent addition to the capital structure and that the company is unlikely to meaningfully deleverage the balance sheet over time. While the analyst acknowledged that the announced acquisition gives WisdomTree increased scale in Europe, diversified AUM and is expected to be accretive to earnings, he noted that it would reduce the probability of WisdomTree being acquired in the near-term. PRICE ACTION: In late morning trading, shares of WisdomTree have dropped about 6.5% to $11.17.

11:15 EDT WisdomTree to lower dividend to 3c from 8c per share - As previously reported, WisdomTree Investments announced that it has entered into a definitive agreement to acquire ETF Securities' European exchange-traded commodity, currency and short-and-leveraged business. Under the terms of the agreement, WisdomTree will exchange $253M of cash and stock consideration of 30 million WisdomTree shares for the Acquired Business. Based on Friday's market close price, the total consideration is valued at $611M. Excluding one-time transaction and integration costs, WisdomTree expects that the acquisition will be immediately accretive to its earnings per share. As part of that announcement, WisdomTree said it will adjust its quarterly dividend to 3c per share, starting with the dividend scheduled for payment in the first quarter of 2018. "This dividend level appropriately balances our new capital structure and allows for the pursuit of future growth opportunities while continuing to return capital to shareholders," the company stated. In late morning trading, WisdomTree shares are down 76c, or 6.4%, to $11.18.

11:03 EDT eBay to match rivals' prices on many top deals beginning today - eBay (EBAY) says that "With many retailers announcing their top Black Friday deals in advance, eBay will match the prices on many of those same top deals beginning today, making it easy to shop from home or on-the-go and feel confident about receiving the best price available. Shoppers can take advantage of these early deep discounts with new deals every day through November 17, all with fast and free shipping on new items from top brands like Ninja, Samsung (SSNLF), and Apple (AAPL), among others... From Black Friday through Cyber Monday, eBay will continue to give shoppers what most other retailers may not - Price Match Guarantee on more than 50,000 deals with no blackout periods. eBay's Price Match Guarantee ensures shoppers will get the best value on top gifts across all categories, from the latest tech gadgets to the must-have toys for the holiday, because eBay will match the best price from competitors."

10:50 EDT AB InBev: Michael Doukeris to succeed Joao Castro Neves as head of North America - Anheuser-Busch InBev announced that Michel Doukeris has been appointed Zone President North America and CEO of Anheuser-Busch, effective January 1, 2018. Michel presently serves as Chief Sales Officer of AB InBev. He succeeds Joao Castro Neves, who decided to step down from the role to pursue other opportunities, and will support Michel during a transitional period.

10:33 EDT Comtech announces $73.8M multi-year contract - Comtech Telecommunications announced that during its first quarter of fiscal 2018, its Safety and Security Technologies group has been awarded a multi-year contract with an estimated value of approximately $73.8M from a "major U.S. telecommunications company" for implementation and continued maintenance and operational support related to wireless enhanced 9-1-1 solutions. Fred Kornberg, President and CEO of Comtech Telecommunications, stated, "This contract award is a testament to the quality and high reliability of Comtech's market-leading Safety and Security Technology solutions. I believe this award is the first of several contracts we will receive from this important customer in fiscal 2018."

10:27 EDT Royal Dutch Shell upsizes sell down of shares in Woodside Petroleum - Further to the announcement on November 13, Royal Dutch Shell (RDS.A, RDS.B) confirms that, following strong demand from institutional investors, Shell Energy Holdings Australia Limited has upsized its previously announced agreement to sell shares in Woodside Petroleum Limited (WOPEY). A total of 111.8 million shares were agreed to be sold, representing 13.28% of the issued share capital of Woodside and the entirety of SEHAL's total shareholding in Woodside, for total pre-tax proceeds of $2.7B. Completion is expected to take place on November 14, with settlement expected on November 16.

10:23 EDT ProQR Therapeutics epidermolysis bullosa treatment granted EU orphan designation - The orphan designation was assigned by the EU on November 10, according to a post to a European Commission website. Reference Link

10:01 EDT W. R. Berkley declares special cash dividend of 50c per share - W. R. Berkley announced that its Board of Directors has declared a special cash dividend on its common stock of 50c per share to be paid on December 14 to stockholders of record at the close of business on November 30. Together with the 50c per share special dividend that was paid on July 5, this brings special dividends during 2017 to $1.00 per share.

09:49 EDT Cherokee amends credit facility with Cerberus - Cherokee Global Brands announced the amendment, subject to the satisfaction of certain conditions, of its senior secured credit facility. The amendment, among other things, eliminates the requirement that the company, under certain circumstances, exercise its rights to call the equity commitment rights under certain common stock purchase agreements dated August 11. Upon the effectiveness of the amendment, such commitments are expected to no longer be in effect, and none of the company, the lenders under the senior secured credit facility or the investors under such agreements would have the right to require the investors to purchase the company's common stock under such agreements. As a result, the special meeting of stockholders that had been called for November 28 to approve such issuances is expected to be cancelled. The amendment also provides, as a condition to the effectiveness of the amendment, that investors purchase participations from the lenders under the senior secured credit facility in an aggregate amount of no less than $11.5M on or before December 8. Cherokee added that it is in advanced discussions with investors who have indicated an interest in purchasing such participation interests and anticipates that it will announce a completion of that investment on or before December 8. Henry Stupp, CEO of Cherokee, said, "The amendment revises the financial covenants materially to enable the company to focus on growing the business for the long term. Importantly, as part of the amendment, we have eliminated the liquidity call which could have potentially resulted in the issuance of approximately $5.5 million in additional common stock. The amendment of our credit facility is a very positive development for the Company and important to stabilizing our balance sheet, sustaining liquidity and better positioning us for profitable future growth."

09:36 EDT Tyson Foods says additions in pork industry 'playing out as expected'

09:33 EDT GE CEO: 'We understand how important the dividend is for our shareholders'

09:31 EDT Theravance Biopharma, Mylan announce submission of NDA for revefenacin - Theravance Biopharma (TBPH) and Mylan (MYL) today announced the submission of a New Drug Application, or NDA, to the U.S. Food and Drug Administration for revefenacin, an investigational long-acting muscarinic antagonist as a once-daily, nebulized bronchodilator in development for the treatment of chronic obstructive pulmonary disease. "This submission represents a key step in our efforts to bring the first once-daily nebulized LAMA to the COPD patient community. While a significant number of COPD patients require or prefer nebulized therapy, these same patients currently have no access to a nebulized LAMA, broadly considered the cornerstone of COPD maintenance therapy. We are pleased with the comprehensive data package that was generated through our Phase 3 efficacy and safety studies and look forward to the FDA's review of our NDA," said Brett Haumann, Chief Medical Officer at Theravance.

09:29 EDT Theravance Biopharma, Mylan announce submission of NDA for revefenacin

09:27 EDT Tyson Foods says has 'tremendous momentum' heading into 2018 - Says Q1 "off to a great start."

09:22 EDT Pfizer names Albert Bourla COO - Pfizer announced that Albert Bourla has been named COO effective January 1, 2018. Bourla has been the Group President of Pfizer's Innovative Health Business since the beginning of 2016. Under his leadership revenues for the Pfizer Innovative Health business grew 11% operationally in 2016 and in the first nine months of 2017 have grown 9% operationally. Effective January 1, 2018 John Young, Group President, Pfizer Essential Health becomes Group President, Pfizer Innovative Health. Angela Hwang, Global President and General Manager for Pfizer Inflammation & Immunology will succeed John Young as Group President, Pfizer Essential Health.

09:17 EDT Tyson Foods says sees prepared foods volume growth of about 10% in 2018

09:14 EDT Tyson Foods says chicken demand remains strong - Sees approximately 3% volume growth in chicken segment in 2018.

09:12 EDT General Electric CEO says focused on maximizing shareholder value

09:08 EDT Shineco provides update on further cooperation with Daiso via JD.com - Shineco (TYHT) announced that it has further developed the cooperation with Daiso Industries Co., Ltd. through a supply and purchase agreement entered into on November 3, 2017. As previously disclosed in the press release on October 27, 2017, Shineco is authorized to distribute Daiso's branded products via JD.com (JD), through its subsidiary, Tianjin Tajit E-Commerce Ltd. The Agreement was entered into for the purpose of establishing a continuous supply and sale of Daiso's products in China. Pursuant to the Agreement, Shineco shall purchase Daiso Products in the amount of approximate RMB 20M no later than December 31, 2017 and add orders as circumstance requires. The term of the Agreement is currently one year, and it extends for one additional year at each expiration date unless written notice of termination is given by either of the parties of the Agreement.

09:07 EDT Roku offering $20 off new Roku Streaming Stick+ for Black Friday weekend - Roku, Inc. announced it is offering a deep holiday discount on the new Roku Streaming Stick+ across retailers nationwide for the Black Friday weekend. "The Roku Streaming Stick+, which is great for high-performance portability, 4K and HDR TVs and TVs further from a router, regularly retails for $69.99 MSRP. During Black Friday weekend, the Roku Streaming Stick+ will be available for $49.99 MSRP for a limited time at participating retailers and Roku.com, starting on Thursday, Nov. 23, at 12:01 a.m. ET/Wednesday, Nov. 22, at 9:01 p.m. PT. The offer will run through Monday, Nov. 27, at 11:59 p.m. PT, while supplies last."

09:06 EDT Roku says Funai Electric joins TV licensing program - Roku announced that Funai Electric has joined the Roku TV licensing program. Funai Electric will leverage the Roku TV platform to build and deliver smart TVs under the Philips brand that run the Roku OS. Philips Roku TV models are expected to be available in the U.S. this year.

09:05 EDT Terex announces aerial agreement amid presidential trade mission in China - Terex Corporation joined 27 other companies on the U.S. Trade Mission to China led by President Donald Trump and Secretary of Commerce Wilbur Ross and hosted by China President Xi Jinping. The mission's purpose was to promote commercial opportunities for U.S. business in China. Joining Terex at official trade delegation events were Xuzhou Handler Special Vehicles Co., Ltd., the distributor for Terex Utilities products in China; and Shanghai Horizon Equipment & Engineering Co., Ltd, China's leading aerial work platform rental business and a valued customer of Genie equipment. During the mission, Terex Utilities and Xuzhou Handler signed a letter of intent for Xuzhou to purchase 5,000 units of insulated aerial devices from Terex over a five-year period, with a total value of more than USD 250 million. These products will enable and support the continuing improvement and ongoing adoption of live line work practices in the Chinese public utility sector. The signing was witnessed by Secretary Ross and China's Vice Premier Wang Yang.

09:04 EDT CytRx provides business update, announces new shareholder initiatives - CytRx provided a business update and announced new shareholder relations initiatives. Prior to and since implementing a reverse stock split on November 1, 2017, CytRx has been diligently working on various initiatives to advance and grow the company and create long-term shareholder value. The Company has selected four lead compounds from its LADR technology platform and presently plans to file patent applications during the fourth quarter of 2017 and nominate at least one candidate for human clinical trials during the first quarter of 2018. The CytRx development team was recently streamlined and the Company is leveraging renowned drug development strategist Dr. Margaret Hurley and her world-class team at Hurley Consulting Associates Ltd. to advance our future drug candidates into clinical trials. CytRx believes it has the right team, resources and strategic focus to achieve its corporate goals and facilitate future growth. Going forward, CytRx will be implementing a number of initiatives designed to enhance transparency and increase the frequency of communication with its shareholders. First, the Company plans to conduct quarterly conference calls, starting with the filing of its year end 2017 financials in March 2018 and then for subsequent quarterly filings. The Company will also be making more frequent updates to its corporate website. CytRx will continue to provide updates on the progress of both aldoxorubicin (by its licensee NantCell) and the discovery laboratory activities around its innovative LADR candidates. In addition, CytRx is focused on rebuilding its institutional shareholder base, and to that end, will be increasing its participation in both industry and investor conferences, non-deal roadshows, and face-to-face meetings with certain prospective shareholders.

09:02 EDT Apollo Global names Scott Kleinman, James Zelter co-presidents - Apollo Global Management, LLC announced the expansion of its executive leadership team with the elevation of Scott Kleinman and James Zelter to serve as Co-Presidents. In connection with these appointments, the current roles of Leon Black, Chairman, CEO and Founder, Josh Harris, Senior Managing Director and Co-Founder, and Marc Rowan, Senior Managing Director and Co-Founder, will continue with respect to Apollo's strategic leadership and investment committee decision-making. In their new capacities, Kleinman and Zelter will have full responsibility for all of Apollo's revenue-generating and investing businesses. Kleinman will focus on Apollo's equity and opportunistic businesses, and Zelter will focus on Apollo's credit and yield businesses. They both will continue to serve on the investment committees in their respective areas of focus.

09:01 EDT Ciena, partner selected to upgrade network for ONTRAS Gastransport - Ciena and its partner Kapsch CarrierCom have been selected by ONTRAS Gastransport GmbH to implement a packet network. The network upgrade will enable Germany's second largest gas transmission operator to introduce new security features to its facilities, improve data processing and address current and forthcoming industry legislation.

08:52 EDT Qualcomm board unanimously rejects Broadcom's unsolicited proposal - Qualcomm (QCOM) announced that its Board of Directors unanimously rejected the unsolicited proposal announced by Broadcom (AVGO) on November 6, 2017. "It is the Board's unanimous belief that Broadcom's proposal significantly undervalues Qualcomm relative to the Company's leadership position in mobile technology and our future growth prospects," said Paul Jacobs, Executive Chairman and Chairman of the Board of Qualcomm Incorporated. "No company is better positioned in mobile, IoT, automotive, edge computing and networking within the semiconductor industry. We are confident in our ability to create significant additional value for our stockholders as we continue our growth in these attractive segments and lead the transition to 5G," said Steve Mollenkopf, CEO of Qualcomm Incorporated. "The Board and Management are singularly focused on driving value for Qualcomm's shareholders. After a comprehensive review, conducted in consultation with our financial and legal advisors, the Board has concluded that Broadcom's proposal dramatically undervalues Qualcomm and comes with significant regulatory uncertainty. We are highly confident that the strategy Steve and his team are executing on provides far superior value to Qualcomm shareholders than the proposed offer," said Tom Horton, Presiding Director for Qualcomm Incorporated.

08:48 EDT GE announces new compensation program - Says higher equity mix targeted for top 5,000 employees. Says 100% of CEO equity issued in performance share units. Annual bonus program tied to segment performance & simplified to 2-3 metrics. Eliminating 3-year cash long-term performance award. Conforming other benefits to market norms

08:47 EDT General Electric sees 2018 organic revenue growth 0%-3% - Sees margins 0-40bps, industrial profit 2%-7%. Sees lower CapEx spend in 2018, higher continuing net income. Sees 2018 Power organic revenue down 10%, Renewable Energy organic revenue up 7%-10%, Oil & Gas organic revenue up 2%-5%, Aviation organic revenue up 7%-10%, Healthcare organic revenue up about 3%, Transportation organic revenue down about 15%, Lighting organic revenue up about 5%. Sees "soft" market for Transportation. Says O&G volatility persists, BHGE deal fundamentals strong. Not planning for dividend from GE Capital in 2018. Long-term, GE is targeting 2%-4% organic growth, 50+ bps. margin expansion, FCF conversion 90-100%.

08:46 EDT Chipotle shares slide after 'Supergirl' star blames chain for illness - Shares of Chipotle Mexican Grill (CMG) are down in pre-market trading after actor Jeremy Jordan, one of the stars of the television show "Supergirl," blamed the burrito chain for an illness that hospitalized him. On Thursday night, Jordan posted his first ever Instagram story, which included pictures of himself in a hospital bed and the statement :"I, as you can see, am in the hospital and I have fluids in my arm because the food did not agree with me and I almost died." Chipotle responded to Jordan's claims with the following statement to People: "We are sorry to hear that Jeremy is sick and have attempted to get in touch with him directly regarding where and when he ate so we can look into this. We take all claims seriously, but at this time we can't confirm any link to Chipotle. We are always committed to making things right for our guests and will do the same for Jeremy when we are able to reach him." In pre-market trading, Chipotle is down $11.45, or 4%, to $268 per share. Reference Link

08:42 EDT General Electric sees challenges for GE Power continuing in 2018 - Expect challenging market into 2019, driving additional cost out.

08:40 EDT GE says exiting $20B+ of assets over 1-2 years - Says focusing on the core, exiting $20B+ of assets in 1-2 years; Transportation, Industrial Solutions, Current & Lighting and 10+ other transactions. Says reducing volatility and commodity exposure, BHGE optionality.

08:38 EDT LightInTheBox reports 15.6% YoY sales growth on 'Singles Day' - LightInTheBox announced that sales on Chinese "Singles Day", which took place on November 11, 2017, increased 15.6% when compared to the same day last year. Sales made through the Company's main platform LightInTheBox.com website and app increased 30% when compared to "Singles Day" 2016. Sales on mobile devices increased 84% including an over 200% increase in sales made through the Company's mobile app when compared to the same day last year. Emerging markets such as India, Russia and the Gulf Corporation Council demonstrated strong growth. Alan Guo, Chairman and CEO of LightInTheBox, commented, "We are pleased with the 15.6% sales increase over 'Singles Day' 2016 which marks a great start to our holiday sales season."

08:38 EDT General Electric establishing Finance & Capital Allocation committee on board - Says taking a "rigorous," in-depth review of all aspects of the company. 2018 capital allocation priorities include: Strengthening cash position, balanced capital allocation, funding principal pension plan through 2020, disciplined financial policy. Says establishing a new finance & capital allocation committee of the board, with increased oversight of M&A and buyback. Says directors "highly supportive and aligned to driving change."

08:35 EDT Aspen Group receeives approval from WSCUC to acquire United States University - Aspen Group announced it has received approval of its Change of Ownership application from the WASC Senior College and University Commission, or WSCUC, to complete the acquisition of United States University. United States University has additionally filed change of ownership documentation with the Department of Education, state regulatory and programmatic accreditation bodies. Aspen Group is targeting to close the acquisition of United States University on or around December 1, 2017. Upon the completion of the acquisition, Aspen Group will continue to operate United States University as an independent, for-profit university governed by its own board of trustees, with no intent to merge United States University and Aspen University in the future.

08:31 EDT Ruth's Hospitality names Stephen M. King to board - Ruth's Hospitality Group announced that Stephen M. King has been appointed to serve as an independent member of the Board of Directors effective January 1, 2018. With his appointment, the Board will be comprised of eight members, seven of whom are independent. King will stand for election by vote of the shareholders at the company's next annual meeting. King is Chairman and CEO of Dave & Buster's Entertainment.

08:26 EDT GBT announces completion of safety review by DSMB for HOPE study - Global Blood Therapeutics, or GBT, announced that the independent Data and Safety Monitoring Board, or DSMB, for the Phase 3 HOPE, or Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization, Study evaluating voxelotor for the treatment of sickle cell disease, or SCD, has completed its first scheduled clinical safety review. No drug-related serious or severe adverse events were reported in either of the voxelotor treatment arms, and there were no discontinuations due to adverse events. Based on this review, the DSMB did not identify safety concerns with voxelotor at either dose level across all patients dosed in the ongoing SCD clinical program, including adult patients in the Phase 3 HOPE Study and adolescent patients in the HOPE-KIDS 1 Study. Based on the available safety data to date, including at the high dose level of 1500 mg, the DSMB recommended that the pivotal study continue as planned and approved initiation of enrollment in adolescent patients age 12 to 17.

08:20 EDT Quest Diagnostics, Clinical Genomics announce FDA 510(K) clearance of InSure ONE - Clinical Genomics and Quest Diagnostics announced FDA clearance of InSure ONE, a convenient at-home collection, fecal immunochemical test, or FIT, intended to detect blood in stool, that may improve compliance for screening programs. Clinical Genomics manufactures InSure FIT tests, including InSure ONE, which Quest provides to physicians and organized provider groups, including through specialized programs with Accountable Care Organizations, or ACOs, across the United States. InSure ONE is expected to be commercially available in early 2018.

08:17 EDT Intra-Cellular appoints Dr. Andrew Satlin as Chief Medical Officer - Intra-Cellular announced that Andrew Satlin M.D. has joined the company as Executive Vice President and Chief Medical Officer. Dr. Satlin brings broad experience to the Company with over 20 years of industry experience in all phases of drug development in multiple therapeutic areas, including neurology and psychiatry, as well as cardiovascular and metabolic disorders. Dr. Satlin has extensive expertise in the design and conduct of clinical trials in Alzheimer's disease, Parkinson's disease, epilepsy, schizophrenia, depression, anxiety, heart failure and hypertension.

08:14 EDT BNY Mellon to launch specialist multi-asset investment manager in 2018 - BNY Mellon announced that it will launch a specialist multi-asset investment manager in 2018. The new business will combine BNY Mellon's three largest U.S. investment managers - Mellon Capital Management, Standish Mellon Asset Management, and The Boston Company Asset Management, to offer institutional and intermediary clients high quality single and multi-asset investment strategies in both active and passive solutions. The new business will be headquartered in Boston and led by Chairman and CEO Des Mac Intyre, currently CEO of U.S. Asset Management at BNY Mellon IM. Des most recently served as Head of Investment Process Oversight at Bridgewater Associates. Previously, he served as the Chairman and Chief Executive Officer of Standish. His investment management experience spans more than three decades and includes roles as Chief Operating Officer at Pareto Partners and Head of Risk and Treasurer for GM Asset Management. The combination of the three businesses is expected to be completed within 12 months. During this transition period, MCM, Standish and TBCAM will maintain their existing product brands until the launch of a unified brand later in 2018.

08:11 EDT Orexigen announces distributorship pact with Merck KGaA for Contrave - Orexigen Therapeutics (OREX) announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Merck KGaA (MKGAY), Darmstadt, Germany have executed a distributorship agreement for Contrave in Latin America, including Brazil and Mexico. Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will be responsible for all commercialization and regulatory activities and will own marketing authorization in the region. Orexigen will receive an upfront payment and other potential regulatory and sales milestones, which have not been disclosed. In addition, Orexigen will be responsible for product supply.

08:09 EDT GGP confirms receipt of unsolicited proposal from Brookfield Property - GGP Inc. (GGP) confirmed that on Saturday, November 11, 2017, the company's Board of Directors received an unsolicited proposal from Brookfield Property Partners L.P. (BPY) for BPY to acquire all of the outstanding shares of common stock of GGP other than those shares currently held by BPY and its affiliates. According to the Proposal, each GGP stockholder would be entitled to elect to receive consideration per GGP common share of either $23.00 in cash or 0.9656 of a limited partnership unit of BPY, subject in each case to pro-ration based on a maximum cash component of 50% of the aggregate offer and a maximum stock component of 50% of the aggregate offer. The Board has formed a special committee of its non-executive, independent directors which, in consultation with its financial and legal advisors, will carefully review and consider the Proposal and pursue the course of action that it believes is in the best interests of the company's stockholders. The company's stockholders do not need to take any action at this time. Goldman Sachs & Co. LLC. is serving as financial advisor and Simpson Thacher & Bartlett LLP is serving as legal counsel to the Special Committee. Citigroup Global Markets Inc. is serving as financial advisor and Sullivan & Cromwell LLP is serving as legal counsel to GGP.

08:06 EDT TheStreet announces new employment agreement with Jim Cramer through 2021 - TheStreet announced that it has entered into a new four-year agreement with Jim Cramer, the Company's founder, financial markets commentator and a director of the Company. Cramer will continue his role trading his multi-million-dollar Charitable Trust portfolio at Action Alerts PLUS. He will also continue to host events, author articles and provide video content for the Company's subscription products and distribution channels, most notably Real Money and TheStreet.com. The new agreement is effective January 1, 2018 and will expire on December 31, 2021.

08:04 EDT TheStreet announces new 5M share repurchase program - The company announced that its Board of Directors has approved a new share buyback program authorizing the repurchase of up to 5M shares of the company's common stock, which equates to approximately 10% of the shares outstanding following the preferred stock exchange and common stock financing also announced earlier.

08:02 EDT Kala Pharmaceuticals names Todd Bazemore as COO - Kala Pharmaceuticals announced the appointment of Todd Bazemore as COO. He will report directly to Mark Iwicki, Chairman and CEO Kala Pharmaceuticals and is expected to join Kala on November 20. Prior to joining Kala Pharmaceuticals, Todd served as EVP and COO of Santhera Pharmaceuticals USA.

08:01 EDT TiVo names Enrique Rodriguez as president and CEO - TiVo Corporation (TIVO) announced that its Board of Directors unanimously elected Enrique Rodriguez to the position of president and CEO effective today. Rodriguez also joins the company's Board of Directors. Most recently, he was executive vice president and chief technical officer of AT&T's (T) Entertainment Group. Rodriguez succeeds Thomas Carson, who announced his intention to retire earlier this year. Carson, who is also stepping down from the Board of Directors as of today, will stay on in an advisory capacity through the beginning of the second quarter of 2018 to assist in the CEO transition.

07:55 EDT Premier issues statement of marketplace competition - Premier issued the following statement in response to speculation that new market entrants will disrupt Premier and other companies that have group purchasing organizations serving the healthcare provider industry. The company said, "There has been recent speculation that new market participants are contemplating entrance into the healthcare supply chain with the intent to disintermediate GPOs. Over its more than 20-year history, Premier has evolved from a group purchasing and benchmarking organization, cooperatively owned by our member-owner healthcare providers, into a mission critical partner, offering clinical, operational and administrative solutions and managing over $56B in supply chain spend. The transformation of our company has been driven by our member owners' critical need to harness the collective power of our organizations in solving their most pressing cost, quality and safety issues as they continue their evolution to value-based care. This alignment is evidenced by their commitment and ownership in Premier. As an organization, we continually evaluate our competitive positioning within the marketplace and how to augment our value proposition to our provider partners. Together with our 167 member owners, 3,900 hospitals and health systems, and 150,000 other providers, we are highly confident in our ability to continue to drive the transformation of high quality, cost effective healthcare. Among the many reasons these groups continue to partner with Premier, below is a brief summary. Premier's efficient channel is driving optimum savings for providers...Premier's data and analytic tools provide differentiated value to healthcare providers...Premier defines value for its members beyond unit cost...Premier deploys a dynamic set of capabilities to extract value for its members... Premier deploys efficient e-commerce capabilities across healthcare.

07:38 EDT Tyson Foods raises quarterly dividend to 30c per share - On November 10, the board increased the quarterly dividend previously declared on August 10, to 30c per share on Class A common stock and 27c per share on Class B common stock. The increased quarterly dividend is payable on December 15, to shareholders of record at the close of business on December 1. The board also declared a quarterly dividend of 30c per share on Class A common stock and 27c per share on Class B common stock, payable on March 15, 2018, to shareholders of record at the close of business on March 1, 2018. The company anticipates the remaining quarterly dividends in fiscal 2018 will be 30c and 27c per share of Class A and Class B stock, respectively. This results in an annual dividend rate in fiscal 2018 of $1.20 for Class A shares and $1.08 for Class B shares, or a 33% increase compared to the fiscal 2017 annual dividend rate.

07:34 EDT JetBlue still sees Q4 RASM down 3% to flat vs. last year - JetBlue continues to expect fourth quarter revenue per available seat mile growth to range between (3.0) and 0.0 percent compared to the fourth quarter of 2016, including a negative impact from hurricanes of one to two percentage points.

07:34 EDT JetBlue reports preliminary October traffic up 3.7%, capacity up 6.8% - JetBlue Airways reported its preliminary traffic results for October 2017. Traffic in October increased 3.7% from October 2016, on a capacity increase of 6.8%. Load factor for October 2017 was 82.4%, a decrease of 2.4 points from October 2016. JetBlue's preliminary completion factor was 97.8% and its on-time performance was 79.5%.

07:32 EDT CEL-SCI provides update on arbitration against former CRO - CEL-SCI Corporation announced an update on its arbitration with its former clinical research organization. The last witness in the arbitration hearing testified on Wednesday, November 8, 2017, and no further witnesses or testimony are expected. With that final witness, the testimony phase of the arbitration concluded. All that remains at the trial level are closing statements and post-trial submissions. In 2013, CEL-SCI filed an arbitration seeking $50M from its former CRO that used to run the Company's Phase 3 head and neck cancer study with Multikine. CEL-SCI's arbitration claim alleges breach of contract, fraud in the inducement, and common law fraud. The former CRO was replaced in the spring of 2013 and the Company's Phase 3 head and neck cancer study has enrolled nine hundred twenty-eight newly diagnosed head and neck cancer patients. All the patients who have completed treatment continue to be followed for protocol-specific outcomes in accordance with the study protocol.

07:26 EDT PayPal suspends TIO operations after finding security vulnerabilities - PayPal announced late Friday that TIO Networks, a publicly traded company it acquired in July, has suspended operations to protect TIO's customers. "This suspension of services is a result of PayPal's discovery of security vulnerabilities on the TIO platform and issues with TIO's data security program that do not adhere to PayPal's information security standards," the company said in a press release. It added, "TIO is not integrated into PayPal's platform. The PayPal platform is not impacted by this situation in any way and PayPal's customers' data remains secure. Upon the recent discovery of this vulnerability on the TIO platform, PayPal took action by initiating an internal investigation of TIO and bringing in additional third-party cybersecurity expertise to review TIO's bill payment platform. A focus of the investigation will also include TIO's practices and representations prior to the acquisition." The company noted that it is working with the appropriate authorities to safeguard TIO customers and that its investigation is ongoing.

07:17 EDT Bombardier expects 450 new 60-150 seat aircraft in Middle East - Bombardier Commercial Aircraft's Market Forecast 2017-2036 covering the 60 to 150-seat segment sees growth in the Middle East with expected delivery of 450 aircraft in that market segment, or four per cent of the forecast 12,550 deliveries worldwide with a total value of $820B. The large regional aircraft category will account for 200 deliveries, while the small single-aisle category will take 250 aircraft. This will result in a fleet 3.4 times larger than at present. The Forecast says that although Middle East airlines were profitable in 2016, the trend is downward. Double-digit capacity increases in the last two years to gain market share were achieved at the expense of decreasing yields due to the emergence of low-cost carriers in the region. The U.S. attempts to curb air travel from some Middle East countries has also put pressure on the region's widebody driven business model. This will result in a slowdown of widebody aircraft deliveries. Middle East airlines now have an opportunity to re-examine and re-balance their fleet mix in order to develop intra-regional connectivity which has been largely bypassed in favor of inter-regional networks, to fit demand to capacity. Right-sizing of the fleet will lead to higher intra-regional market and penetration and improve yields, the Forecast says.

07:11 EDT ProQR Therapeutics doses first LCA 10 patient in Phase 1/2 clinical trial - ProQR Therapeutics announced that the first patient has been dosed in the Phase 1/2 open-label trial assessing the safety, tolerability, pharmacokinetics and efficacy of QR-110. The trial will enroll approximately six adults and six children who have Leber's congenital amaurosis 10, or LCA 10, due to the p.Cys998X mutation in the CEP290 gene. Subjects will receive a dose of QR-110 every three months for a total of four doses in one eye. The trial is planned to be conducted at three specialized centers: the University of Iowa, Iowa City, IA, US, the Scheie Eye Institute at the University of Pennsylvania, Philadelphia, PA, US and the Ghent University Hospital, Ghent, Belgium.

07:07 EDT RXi Pharmaceuticals, Gustave Roussy announce research collaboration - RXi Pharmaceuticals and Gustave Roussy announced that they have entered into a collaborative research agreement to evaluate the potential of RXi's novel sd-rxRNA technology platform for use in cancer treatments. The agreement covers research to design and evaluate sd-rxRNA compounds in a human tumor xenograft model. Positive results may lead to further development of these compounds for treatment of cancer.

07:05 EDT ION Geophysical regains NYSE compliance - ION Geophysical announced that it has regained compliance with the New York Stock Exchange's share price continued listing standards. On November 9, 2017, the NYSE notified ION that it was back in compliance due to the company's performance with respect to the business plan submitted to the NYSE and compliance with the NYSE's minimum market capitalization requirement over the past two quarters. Accordingly, the company's common stock will continue to be listed on the NYSE.

07:02 EDT Opus Bank announces resignation of CFO Nicole Carrillo - Opus Bank announced that Nicole M. Carrillo, Opus' EVP, CFO, has resigned from her position with Opus effective November 9, 2017 and will continue as a consultant. Carrillo concurrently resigned from her positions as a director of the Opus Community Foundation and Opus Financial Partners. Additionally, Opus announced today that Kevin L. Thompson has joined Opus as EVP, CFO, effective November 10, 2017 and has been appointed to Opus' Executive Committee. Thompson joins Opus most recently from Midland States Bancorp, where he served as EVP and CFO since 2016.

06:58 EDT Gannett realigns organization with focus on two primary businesses - Gannett USA TODAY NETWORK announced an organizational change that more definitively aligns with the company's refreshed business strategy, which focuses on two primary businesses: Marketing Solutions and Consumer. Leading marketing solutions will be Sharon Rowlands, CEO of ReachLocal, who has been named president, USA TODAY NETWORK Marketing Solutions. Leading the consumer business will be Maribel Perez Wadsworth, current chief transformation officer, who has been named president, USA TODAY NETWORK. As part of the new structure, Kevin Gentzel's role as chief revenue officer will expand to leading all advertising and marketing solutions revenue in North America. He will report to Rowlands. Gentzel will continue to lead national sales, GET Creative, revenue operations and sports media teams, and add all local sales and sales support teams, which include automotive and recruitment verticals, and client analytics. Additionally, Kris Barton has been named chief product officer, USA TODAY NETWORK, reporting to Rowlands. Finally, in light of Zidich's upcoming retirement, Gannett Publishing Services will report to Ali Engel, senior vice president, chief financial officer and treasurer at Gannett.

06:57 EDT Visteon partners with American Center for Mobility - Visteon is joining forces with the American Center for Mobility, or ACM, in Southeast Michigan to support the development and testing of connected and automated transportation technologies. With a $5M strategic investment, Visteon is the first Tier 1 automotive supplier to join as a Founder-level sponsor of the Center. The American Center for Mobility is a world-class non-profit testing and product development facility at the historic Willow Run site in Ypsilanti, Michigan, dedicated to leading the safe development of automated technologies and vehicles onto America's roads.

06:46 EDT Waddell & Reed reports AUM $81.5B as of October 31 - Compared to $80.9B on September 30.

06:34 EDT Banro says it continues to face significant operational, financial challenges - Banro Corporation announced that it continues to face significant ongoing, operational and financial challenges including short and long term liquidity constraints. The company's ability to continue operations in the normal course of business is dependent on several factors, including securing funding for operations and to meet upcoming debt servicing and working capital requirements. In addition, mining operations at the company's Namoya mine in Maniema Province of the Democratic Republic of the Congo, or DRC, continue to be suspended due to the ongoing closure of road access to the mine site. Please refer to the company's press release of September 25, 2017. In the event the Company is unsuccessful in addressing these ongoing operational and financial challenges, it may become unable to meet its non-DRC financial obligations as they become due. As previously announced, the board established a special committee comprised of independent directors to identify and make recommendations to the board concerning financing and other strategic options. The Committee has advised the board that, based in part on the opinion of its financial advisor, it has concluded that there is no reasonable prospect that a successful capital raise could be completed at the current time at a level sufficient to refinance the company's existing indebtedness and to address its working capital requirements. Consequently, there is substantial doubt as to the company's ability to continue as a going concern. The Committee reported that it is in discussions with the company's major stakeholders concerning the possible restructuring of the company's non-DRC debt obligations as well as the provision of financing to support the company's ongoing operations in the DRC. There is significant risk that any restructuring of the company's non-DRC debt obligations may result in significant impairment to the value of the equity holders' interests in the company. The company continues to take all steps necessary to ensure the continuity of its operations in the DRC. Due to the significant uncertainty surrounding the company's ability to continue as a going concern, the company will not be in a position to release its interim unaudited condensed consolidated financial statements and related management's discussion and analysis for the period ended September 30.

06:31 EDT General Electric to cut dividend 50% to 12c per share - GE announced that its Board of Directors has determined to set the company's quarterly dividend to a projected payout of 12c per outstanding share of the company's stock. This represents a 50% reduction from the current quarterly dividend of 24c. This change will be effective beginning with the Board's next dividend declaration, which is expected to occur in December.

06:17 EDT Boeing, ALAFCO finalize order for 20 737 MAX 8s - Boeing and ALAFCO Aviation Lease and Finance Company finalized an order for 20 additional 737 MAX 8s at the 2017 Dubai Airshow, doubling the lessor's order book for the MAX airplane. Kuwait-based ALAFCO, a global provider of commercial aircraft leasing products, now has 40 737 MAXs on order. The deal, valued at $2.2B at current list prices, was announced as a commitment at the Paris Air Show.

06:05 EDT Baozun records total order value of RMB4.99B during 2017 Singles Day - Baozun announced that total order value settled through payment gateways on all of its e-commerce channels reached RMB4.99B during Singles Day 2017, almost double the amount achieved on the same day in 2016. Vincent Qiu, CEO of Baozun, commented, "Total order value almost doubled from last year's Singles Day demonstrating the effectiveness of our strategic foresight to adequately plan and cooperate with our brand partners for a massive surge in orders. Our proven operational capabilities, strengthened IT infrastructure and the expanded array of solutions we offer allowed us to settle over 12 million orders on Singles Day, an increase of 87% compared with last year. We remain committed to investing and further developing our IT systems, warehousing and fulfillment infrastructure and increasing operational efficiency throughout our entire business. We will continue to partner with leading international brands that benefit from strong consumer recognition and demand. I am confident in our ability to continue offering more innovative solutions that will support both our long-term growth and strengthen our market leading position."

06:03 EDT WisdomTree to acquire certain assets of ETF Securities - WisdomTree Investments and exchange-traded product sponsor and asset manager, announced that it has entered into a definitive agreement to acquire ETF Securities' European exchange-traded commodity, currency and short-and-leveraged business, which includes $17.6B of assets under management as of November 9, 2017. The acquisition will provide WisdomTree with immediate scale in Europe, an industry leading position in European-listed gold and commodity products, greater AUM diversification globally, and profitability at WisdomTree Europe and in its International Operating segment. With the addition of the Acquired Business, WisdomTree's assets under management would total approximately $66B globally on a pro-forma basis, as of November 9, 2017. The acquisition will secure WisdomTree's spot as the 9th largest ETP sponsor globally and elevate the company to the largest global independent ETP provider1 with significant scale and presence in the two largest ETP markets: Europe and the U.S. Under the terms of the agreement, WisdomTree will exchange $253M of cash and stock consideration of 30M WisdomTree shares for the Acquired Business. Based on Friday's market close price, the total consideration is valued at $611M. Excluding one-time transaction and integration costs, WisdomTree expects that the acquisition will be immediately accretive to its earnings per share. Subject to regulatory approval and other customary closing conditions, the transaction is expected to close in late Q1 of 2018.

06:00 EDT Tesla's Musk says Semi Truck unveil to be webcast live on Thursday at 8pm - Tesla CEO Elon Musk tweeted, "Tesla Semi Truck unveil to be webcast live on Thursday at 8pm! This will blow your mind clear out of your skull and into an alternate dimension. Just need to find my portal gun ..." Reference Link

05:46 EDT Corvus announces updated clinical data from Phase 1/1b study of CPI-444 - Corvus Pharmaceuticals announced updated clinical data from the renal cell carcinoma, or RCC, expansion cohorts of its ongoing Phase 1/1b study of CPI-444 as a single agent and in combination with atezolizumab. Results showed a response rate of 14 percent with single agent CPI-444 and 13 percent for the combination therapy, and a disease control rate of 29 percent and 69 percent for single agent and combination therapy, respectively, in 30 response-evaluable patients. Additionally, biomarker data from the trial showed an association between adenosine pathway gene expression and response to therapy, and resistance to prior anti-PD-(L)1 treatment. The clinical and biomarker data were presented today in an oral session at the Society for Immunotherapy of Cancer's, or SITC, 32nd Annual Meeting in National Harbor, Md., by Jason J. Luke, M.D., a medical oncologist and assistant professor of medicine at the University of Chicago Medicine. CPI-444 is a selective and potent inhibitor of the adenosine A2A receptor. Atezolizumab, developed by Genentech, a member of the Roche Group, is a monoclonal antibody designed to target and bind to a protein called PD-L1. The ongoing Phase 1/1b clinical trial has enrolled more than 225 patients with several tumor types including RCC, non-small cell lung cancer, triple negative breast cancer, melanoma and other tumors. To date, RCC and NSCLC (single agent and combination) cohorts have met the protocol-defined criteria for expansion from 14 to 26 patients. For both the RCC single agent and combination cohorts, criteria for expansion to 48 patients per cohort have been reached. Of 51 patients with RCC enrolled in the study, 69 percent were resistant or refractory to prior anti-PD-(L)1 therapy, having failed those therapies within a median time of 1.6 months prior to enrollment. The RCC patients had several adverse prognostic features including visceral metastases, hepatic metastases, anemia and elevated serum lactate dehydrogenase.

05:34 EDT Novartis Access signs MoU with provincial government of Punjab in Pakistan - The provincial government of Punjab in Pakistan signed a Memorandum of Understanding with Novartis to roll out Novartis Access. Poor patients in the province of Punjab will soon have free access to high-quality medicines from the Novartis Access portfolio targeting four key noncommunicable disease areas, or NCDs,: cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The agreement also includes the implementation of innovative software to track and monitor individual patient access and adherence. The program in Punjab will also involve the deployment of an offspring of the Novartis SMS for Life digital platform, which will use biometric data to create a registry able to help track patient access and adherence. The anonymized data generated by the system will inform both the government and Novartis about disease prevalence, treatment availability and patient outreach, allowing to better serve patients.